Influenza Research, News Articles | Flu Clinical Treatment Studies

Universal FLU-v Influenza Vaccine, Immunogenic and Warrants Further Testing

By

The adjuvanted, broad-spectrum influenza vaccine FLU-v was found to be immunogenic and merits phase 3 development to explore efficacy.

Does Seasonal Influenza Vaccine Increase Risk for Guillain-Barré Syndrome?

By

Brandon May

Researchers determined the risk for Guillain-Barré Syndrome following seasonal influenza vaccination in a real-world study.

CDC Declares Flu Epidemic After Death of 15 Children

FDA to Review Baloxavir for Pediatric Use, Postexposure Prophylaxis of Influenza

By

Diana Ernst, RPh

Baloxavir inhibits the endonuclease activity of the polymerase acidic protein resulting in inhibition of influenza virus replication.

Addressing Parents’ Concerns Improves Influenza Immunization Rates

By

Madeline Morr

Implementation of an influenza immunization program increased vaccinations rates from 44% to 57% the following year.

Neuraminidase Inhibitor Treatment for Influenza B-Related Pneumonia

By

Zahra Masoud

Early neuraminidase inhibitor therapy may result in better outcomes in patients hospitalized with influenza B-related pneumonia.

Fluad Quadrivalent Influenza Vaccine Approved for Older Adults

By

Diana Ernst, RPh

The FDA has approved Fluad Quadrivalent for active immunization in patients 65 years of age and older against influenza disease caused by influenza virus subtypes A and types B contained in the vaccine.

Oseltamivir Not Linked to Increase Risk for Neuropsychiatric Events

By

Infectious Disease Advisor Contributing Writer

No difference was seen in the risk for serious neuropsychiatric events in patients who received oseltamivir in the 30 days after influenza diagnosis compared with those who did not.

Evaluation of Trivalent vs Quadrivalent Inactivated Vaccine for Influenza B

By

Sweta Gupta

Despite the higher effectiveness of the quadrivalent inactivated influenza vaccine against the added B virus lineage, trivalent inactivated influenza vaccine.

Physician giving patient pills, medication

Antibiotic and Antiviral Combination to Treat Influenza

By

Zahra Masoud

Compared with patients prescribed only an antiviral, patients who are prescribed both an antiviral and antibiotic have a lower risk for 3-day respiratory hospitalization.

Influenza Vaccine Effectiveness for 2019-2020 Season Assessed

By

Diana Ernst, RPh

The CDC continues to recommend influenza vaccination as the best method of protection while the viruses are circulating in the community.

Does Race Affect Peripheral Tfh Cells After Influenza Vaccination Among PLWHIV?

By

Zahra Masoud

Black people who are HIV-positive may have a decreased ratio of influenza-specific IgG vs IgM after influenza vaccination.

Double-Dose Influenza Vaccine Doses May Not Benefit Pregnant Women With HIV

By

Infectious Disease Advisor Contributing Writer

A double-dose of inactivated influenza vaccine may not increase the immunogenicity of the vaccine among pregnant women with HIV.

Audenz, an H5N1 Influenza Vaccine, Gets FDA Approval

By

Diana Ernst, RPh

The FDA has approved influenza A [H5N1] monovalent vaccine for active immunization for the prevention of disease in patients 6 months of age and older at increased risk of exposure to the influenza A H5N1 virus subtype contained in the vaccine.

Many US Adults Misinformed About the Flu, Vaccination

Many US adults are misinformed about the influenza virus and the importance of flu vaccination.

Oseltamivir Plus Usual Care Leads to Quicker Recovery of Influenza-Like Illness

By

Bradley van Paridon

Primary care patients with influenza-like illness recovered 1 day sooner on average when treated with oseltamivir compared with those receiving usual care only.

Oral Influenza Vaccine Promising Based on Challenge Study Results

By

Brian Park, PharmD

Vaxart announced positive topline data from a phase 2 study evaluating the H1 influenza oral tablet vaccine, VXA-A1.1, for the prevention of influenza disease.

Enhanced Influenza Vaccines Offer Improved Antibody Response in Older Adults

By

Sweta Gupta

Compared with a standard-dose influenza vaccine, several enhanced influenza vaccines improved humoral and cell-mediated immune responses in older adults.